Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|December 10, 2002
Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanomaJanice P DutcherCurrent Oncology Reports|January 31, 2004
Mammalian target of rapamycin (mTOR) InhibitorsJanice P DutcherLeukemia Research|March 22, 2003
The role of Epstein-Barr virus and elevated levels of tumor necrosis factor in determining prognosis in Asian peripheral T-cell lymphomasJanice P DutcherTherapeutic Advances in Urology|December 3, 2013
Recent developments in the treatment of renal cell carcinomaJanice P DutcherCancer Treatment and Research|December 4, 2003
Interleukin-2 based therapy for kidney cancerJanice P DutcherClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Mammalian target of rapamycin inhibitionJanice P DutcherJournal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 21, 2018
Update on the biology and management of renal cell carcinomaJanice P DutcherAmerican Journal of Therapeutics|August 1, 1994
A Review of the New Cytokines: IL-4, IL-6, IL-11, and IL-12Leslie Oleksowicz, Janice P. DutcherMedical Oncology (Northwood, London, England)|August 19, 2010
Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapyJanice P Dutcher, David NanusJournal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|October 21, 2023
Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigreesPeter H Wiernik, Janice P DutcherPageof 9